Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims Database
Clinical trial NCT06148493 · COMPLETED
Trial details
- NCT number
- NCT06148493
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-20
- Primary completion
- 2022-12-15
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.